Prev: Choosing wisely: the American College of Rheumatology's Top 5 list of things physicians and patients should questionNext: International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies

Record 006 · Clinical guidance · 2003
Diagnosis of Systemic Lupus Erythematosus
American Academy of Family Physicians · requested inclusion
“AAFP evidence-based review of SLE diagnosis reporting the ACR recommendation to order ANA only in patients with two or more unexplained organ-system signs, and the College of American Pathologists guideline on follow-up testing after a positive ANA.”
AAFP evidence-based review of SLE diagnosis reporting the ACR recommendation to order ANA only in patients with two or more unexplained organ-system signs, and the College of American Pathologists guideline on follow-up testing after a positive ANA. Candidate notes: ACR recommends ANA testing only in patients with two or more unexplained signs or symptoms; not indicated for isolated myalgias or arthralgias Persistently negative ANA (<1:40) can usually be assumed to rule out SLE; ANA was positive in 32% of the general population at 1:40 dilution but only 5% at 1:160 CAP guideline: if diagnostic criteria are met plus positive ANA, no further labs are needed; otherwise test anti-dsDNA and anti-Sm and do not test other autoantibodies Limits noted in the record: Dated 2003: predates the EULAR/ACR 2019 criteria and the ANA-as-entry-criterion framework Reports ACR/CAP guidance rather than generating original recommendations A positive ANA is not a diagnosis. Claims in this record are not verified.
A positive ANA is not a diagnosis. Claims in this record are not verified.
source
- follow-up-testing
- healthy-people
- interpretation
- negative-ana
- positive-ana
- systemic lupus erythematosus
Clinical guidance



